Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review.

@article{Pincus2002EvidenceFC,
  title={Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review.},
  author={Theodore Pincus and Gianfranco Ferraccioli and Tuulikki Sokka and Annette H\ojmann Larsen and R. M. Rau and Irving Kushner and Frederick Wolfe},
  journal={Rheumatology},
  year={2002},
  volume={41 12},
  pages={1346-56}
}
Earlier reports, including a comprehensive 1983 review, had indicated that slowing of radiographic progression was relatively unusual in treatment of rheumatoid arthritis (RA) using traditional disease modifying anti-rheumatic drugs. However, in recent years, slowing of radiographic progression has been documented in a number of clinical trials, as well as long-term observational studies, with use of (in alphabetical order) adalimumab, anakinra, corticosteroids, cyclophosphamide, cyclosporin… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 71 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 124 references

Infliximab andmethotrexate in the treatment of rheumatoid arthritis

  • PE Lipsky, DMFM van der Heijde, EW Clair
  • N Engl J Med
  • 2000

Similar Papers

Loading similar papers…